Technical Analysis for BOLD - Audentes Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 31.1 -2.90% -0.93
BOLD closed down 2.9 percent on Tuesday, September 17, 2019, on 1.6 times normal volume.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical BOLD trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
20 DMA Support Bullish -2.90%
200 DMA Resistance Bearish -2.02%
1,2,3 Retracement Bearish Bearish Swing Setup -2.02%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.02%
NR7 Range Contraction -2.02%
1,2,3 Retracement Bearish Bearish Swing Setup -2.29%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.29%
20 DMA Support Bullish -2.29%
Outside Day Range Expansion -2.29%

Older signals for BOLD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Audentes Therapeutics, Inc. is a biotechnology company which focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases. The company's product pipeline consists of AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia and AT982 for the treatment of pompe disease, which are in pre-clinical trial stage. Audentes Therapeutics, Inc. is based in San Francisco, California.
Biotechnology Medical Specialties Organ Systems Rare Diseases Gene Therapy Hepatology Cardiac Arrhythmia Gene Therapy Products Pompe Disease Channelopathies Myopathy Treatment Of Pompe Disease
Is BOLD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.65
52 Week Low 17.95
Average Volume 361,937
200-Day Moving Average 32.7354
50-Day Moving Average 34.5052
20-Day Moving Average 31.3915
10-Day Moving Average 31.174
Average True Range 1.5284
ADX 30.18
+DI 13.0069
-DI 25.8256
Chandelier Exit (Long, 3 ATRs ) 30.3048
Chandelier Exit (Short, 3 ATRs ) 33.8352
Upper Bollinger Band 33.4213
Lower Bollinger Band 29.3617
Percent B (%b) 0.43
BandWidth 12.932163
MACD Line -0.8533
MACD Signal Line -1.1513
MACD Histogram 0.298
Fundamentals Value
Market Cap 864.09 Million
Num Shares 27.8 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -8.84
Price-to-Sales 0.00
Price-to-Book 4.35
PEG Ratio -1.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 33.68
Resistance 3 (R3) 33.70 32.87 33.25
Resistance 2 (R2) 32.87 32.21 32.86 33.11
Resistance 1 (R1) 31.98 31.80 31.57 31.96 32.96
Pivot Point 31.15 31.15 30.94 31.14 31.15
Support 1 (S1) 30.26 30.49 29.85 30.24 29.24
Support 2 (S2) 29.43 30.08 29.42 29.09
Support 3 (S3) 28.54 29.43 28.95
Support 4 (S4) 28.52